CP again denies link to Sinovac buy

CP again denies link to Sinovac buy

Charoen Pokphand (CP) Group has once again denied any involvement in the government's procurement of the Sinovac Covid-19 vaccine from China.

The company was responding to rumours, similar to those spread earlier which had prompted a previous statement on May 25 dismissing the claims.

Its latest remarks followed the cabinet's decision on Tuesday to procure 10.9 million more doses of Sinovac at a cost of 6.1 billion baht.

"Charoen Pokphand Group once again insists the Sinovac vaccine procurement is conducted in a government-to-government (G2G) format only, which has nothing to do with CP either directly or indirectly," it said.

CP backed any proposals for the government to import alternative Covid-19 vaccines to help achieve herd immunity against Covid-19, it said.

Suphachai Chearavanont, chief executive of CP, said the group would work side by side with the country to fight Covid-19.

"CP is confident in the country's ability and the power of unity in the public and private sectors and civic groups," he said.

CP had been affected by the crisis no less than the rest of society, he said.

Do you like the content of this article?

Passenger processing system to check arrivals' health info

The Advance Passenger Processing System (APPS) is being updated to check incoming air passengers for their health documentation ahead of their arrival as the country is set to reopen to international tourism starting next month, according to the Airports of Thailand (AoT).


Myanmar's Suu Kyi goes on trial for incitement, pleads not guilty

Myanmar's junta has put ousted leader Aung San Suu Kyi on trial for incitement, her lawyer said Tuesday, the latest in a list of charges that could see her jailed for decades.


Malaysia reaches herd immunity threshold of 80%: PM

Malaysia has reached its target of fully vaccinating 80% of the adult population, achieving herd immunity for adults against Covid, Prime Minister Ismail Sabri Yaakob said in a tweet on Tuesday.